Literature DB >> 10507980

Myocardial infarction in HIV-infected men receiving protease inhibitors.

T E Flynn, L A Bricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10507980     DOI： 10.7326/0003-4819-131-7-199910050-00032

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  15 in total

Review 1.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

2.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

3.  Cardiovascular and Endothelial Disease in HIV Infection.

Authors:  Michelle S Cespedes; Judith A Aberg
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

Review 4.  Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

Authors:  Carl J Fichtenbaum; John G Gerber
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.

Authors:  Ashok Balasubramanyam; Ivonne Coraza; E O'Brian Smith; Lynne W Scott; Payal Patel; Dinakar Iyer; Addison A Taylor; Thomas P Giordano; Rajagopal V Sekhar; Pamela Clark; Edith Cuevas-Sanchez; Swarna Kamble; Christie M Ballantyne; Henry J Pownall
Journal:  J Clin Endocrinol Metab       Date:  2011-05-11       Impact factor: 5.958

Review 6.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

7.  Coronary artery disease in HIV infected patients.

Authors:  Lelia Escaut; Jean Jacques Monsuez; Gilles Chironi; Mansouriah Merad; Elina Teicher; Denis Smadja; Alain Simon; Daniel Vittecoq
Journal:  Intensive Care Med       Date:  2003-05-09       Impact factor: 17.440

Review 8.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Cardiac involvement in HIV infected people in Yaounde, Cameroon.

Authors:  D Nzuobontane; K N Blackett; C Kuaban
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

10.  Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Authors:  C A Sabin; A d'Arminio Monforte; N Friis-Moller; R Weber; W M El-Sadr; P Reiss; O Kirk; P Mercie; M G Law; S De Wit; C Pradier; A N Phillips; J D Lundgren
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.